Cost-effectiveness evaluations among the direct oral anticoagulants for the prevention and treatment of venous thromboembolism: systematic review
M Al Mukdad, D Al-Badriyeh… - Clinical and Applied …, 2019 - journals.sagepub.com
Venous thromboembolism (VTE) is associated with high recurrence, mortality, and cost
burden. Direct oral anticoagulants (DOACs) are currently used for VTE treatment, and they …
burden. Direct oral anticoagulants (DOACs) are currently used for VTE treatment, and they …
Cost-effectiveness Evaluations Among the Direct Oral Anticoagulants for the Prevention and Treatment of Venous Thromboembolism: Systematic Review
M Al Mukdad, D Al-Badriyeh, HF Elewa - 2019 - qspace.qu.edu.qa
Venous thromboembolism (VTE) is associated with high recurrence, mortality, and cost
burden. Direct oral anticoagulants (DOACs) are currently used for VTE treatment, and they …
burden. Direct oral anticoagulants (DOACs) are currently used for VTE treatment, and they …
Cost-effectiveness Evaluations Among the Direct Oral Anticoagulants for the Prevention and Treatment of Venous Thromboembolism: Systematic Review
M Al Mukdad, D Al-Badriyeh… - Clinical and applied …, 2019 - pubmed.ncbi.nlm.nih.gov
Venous thromboembolism (VTE) is associated with high recurrence, mortality, and cost
burden. Direct oral anticoagulants (DOACs) are currently used for VTE treatment, and they …
burden. Direct oral anticoagulants (DOACs) are currently used for VTE treatment, and they …
Cost-effectiveness Evaluations Among the Direct Oral Anticoagulants for the Prevention and Treatment of Venous Thromboembolism: Systematic Review.
M Al Mukdad, D Al-Badriyeh… - Clinical & Applied …, 2019 - search.ebscohost.com
Venous thromboembolism (VTE) is associated with high recurrence, mortality, and cost
burden. Direct oral anticoagulants (DOACs) are currently used for VTE treatment, and they …
burden. Direct oral anticoagulants (DOACs) are currently used for VTE treatment, and they …
[HTML][HTML] Cost-effectiveness Evaluations Among the Direct Oral Anticoagulants for the Prevention and Treatment of Venous Thromboembolism: Systematic Review
M Al Mukdad, D Al-Badriyeh… - Clinical and Applied …, 2019 - ncbi.nlm.nih.gov
Venous thromboembolism (VTE) is associated with high recurrence, mortality, and cost
burden. Direct oral anticoagulants (DOACs) are currently used for VTE treatment, and they …
burden. Direct oral anticoagulants (DOACs) are currently used for VTE treatment, and they …
[引用][C] Cost-effectiveness Evaluations Among the Direct Oral Anticoagulants for the Prevention and Treatment of Venous Thromboembolism: Systematic Review
M Al Mukdad, D Al-Badriyeh, HF Elewa - Clinical and Applied …, 2019 - elibrary.ru
Cost-effectiveness Evaluations Among the Direct Oral Anticoagulants for the Prevention and Treatment of Venous Thromboembolism: Systematic Review.
M Al Mukdad, D Al-Badriyeh… - Clinical and Applied …, 2019 - europepmc.org
Venous thromboembolism (VTE) is associated with high recurrence, mortality, and cost
burden. Direct oral anticoagulants (DOACs) are currently used for VTE treatment, and they …
burden. Direct oral anticoagulants (DOACs) are currently used for VTE treatment, and they …
Cost-effectiveness Evaluations Among the Direct Oral Anticoagulants for the Prevention and Treatment of Venous Thromboembolism: Systematic Review.
M Al Mukdad, D Al-Badriyeh… - Clinical and Applied …, 2019 - europepmc.org
Venous thromboembolism (VTE) is associated with high recurrence, mortality, and cost
burden. Direct oral anticoagulants (DOACs) are currently used for VTE treatment, and they …
burden. Direct oral anticoagulants (DOACs) are currently used for VTE treatment, and they …